Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiretroviral agents. Current usage

M N Chaudry1, D H Shepp

  • 1Department of Medicine, North Shore University Hospital, New York University School of Medicine, Manhasset, USA.

Dermatologic Clinics
|April 1, 1997
PubMed
Summary

New combination therapies, including protease inhibitors, offer more effective HIV treatment by overcoming drug resistance. Long-term effectiveness data are still needed to fully assess patient prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use.

HIV medicine·2006
Same author

Cytomegalovirus infectivity in whole blood following leukocyte reduction by filtration.

American journal of clinical pathology·2001
Same author

Stavudine resistance: an update on susceptibility following prolonged therapy.

Antiviral therapy·2000
Same author

Evaluation of the PrimeCapture CMV DNA detection plate system for detection of cytomegalovirus in clinical specimens.

Journal of clinical microbiology·1999
Same author

Application of a standardized cytomegalovirus antigenemia assay in the management of patients with AIDS.

Diagnostic microbiology and infectious disease·1998
Same author

Identification of an exogenous retrovirus (foamy virus type 1) in rhesus monkey kidney cell culture: significance to viral diagnostics.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·1998

Area of Science:

  • Infectious Diseases
  • Virology
  • Pharmacology

Background:

  • HIV pathogenesis understanding has advanced.
  • New potent antiretroviral agents have been developed.
  • Combination therapy shows promise for HIV treatment.

Purpose of the Study:

  • To review recent advances in HIV therapy.
  • To discuss the role of combination antiretroviral agents.
  • To highlight promising new treatment regimens.

Main Methods:

  • Review of current antiretroviral agents (nucleoside and nonnucleoside RT inhibitors, protease inhibitors).
  • Analysis of combination therapy effectiveness in overcoming resistance.
  • Evaluation of promising combination regimens, including zidovudine, lamivudine, and indinavir.

Main Results:

  • Combination therapy can overcome limitations of individual agents, particularly resistance.
  • Short-term results of combination regimens are impressive.
  • The combination of zidovudine, lamivudine, and a protease inhibitor is a promising regimen.

Conclusions:

  • Combination antiretroviral therapy represents a new era in HIV treatment.
  • Further long-term data are required to assess the true impact on patient prognosis.
  • Ongoing clinical trials are evaluating additional promising combination regimens.

Related Experiment Videos